Wspolczesne poglady w zakresie norm spozycia folianow

• Autorzy: Kappler E , Gronowska-Senger A.

Warianty tytułu

EN

Current views on recommendations for folate intake

• Języki publikacji: PL

Słowa kluczowe

PL

zywienie czlowieka; spozycie zywnosci; foliany; normy zywienia; harmonizacja norm

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 2002
• Tom: 29
• Numer: 4
• Opis fizyczny: s.278-288,tab.,bibliogr.

Twórcy

autor

Kappler E

• Szkola Glowna Gospodarstwa Wiejskiego w Warszawie, Warszawa

autor

Gronowska-Senger A.

Bibliografia

• 1. Aisen P.S., Egelko S., Andrews H., et al.: A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease. Am. J. Geriatr. Psychiatry 2003, 11, 246-9.
• 2. Almadori G., Bussu F., Galli J., et al.: Serum folate and homocysteine levels in head and neck squamous cell carcinoma. Cancer 2002, 15, 94, 1006-11.
• 3. Boushey C.J., Edmonds J.W., Welshimer K.J.: Estimates of the effects of folic-acid fortification and folic-acid bioavailability for women. Nutrition 2001, 17, 10, 873-879.
• 4. Brilakis E.S., McConnell J.P, Ballman K.V., et al.: Lack of association between plasma homocysteine and angiographic coronary artery disease in the era of fortification of cereal grain flour with folic acid. Atherosclerosis 2002, 165, 375-81.
• 5. Brown C.M., Smith A.M., Picciano M.F.: Forms of human milk folacin and variation patterns. J. Pediatr. Gastroenterol. Nutr., 1996, 5, 278-282.
• 6. Brzeziński J.Z.: Kwas foliowy w zapobieganiu wadom wrodzonym cewy nerwowej. Med. Wieku Rozwojowego 1998, 2, 4, 453-461.
• 7. Caudill M.A., Cruz A.C., Gregory III J.E, et al.: Folate status response to controlled folate intake in pregnant women. J. Nutr., 1997, 127, 2363-2370.
• 8. Colman N, Larsen J.V, Barker M., et al.: Prevention of folate deficiency by food fortification. III. Effect in pregnant subjects of varying amounts of added folic acid. Am. J. Clin. Nutr., 1975, 28, 465-470.
• 9. Commission of the European Communities: Report of the Scientific Committee for Food (Thirty-first series): Nutrient and Energy Intakes for the European Community. Office for Official Publications of the European Communities. Luxemburg 1993, 106-114.
• 10. Cuskelly G.J., McNulty H., Scott J.M.: Effect of increasing dietary folate on red-cell folate: Implications for prevention of neural tube defects. Lancet 1996, 347, 657-659.
• 11. Czeizel A.E., Dudas I.: Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N. Engl. J. Med., 1992, 327, 1832-1835.
• 12. De Bree A., Van Dusseldorp M., Brouwer J.A., et al.: Folate intake in Europe: recommended, actual and desired intake. Eur. J. Clin. Nutr., 1997, 51, 643-660.
• 13. De Bree A., Verschuren W.M., Blom H.J., et al.: Coronary heart disease mortality, plasma homocysteine, and B-vitamins: a prospective study. Atherosclerosis 2003, 166, 369-77.
• 14. Deutsche Gesellschaft für Ernährung: Empfehlungen für die Nährstoffzufuhr. 5. Uberarbeitung, Frankfurt/Main, Umschau-Verlag, 1991, 123-128.
• 15. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. Institute of Medicine, Food and Nutrition Board. Washington DC, National Academy Press, 1997.
• 16. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin and Choline. Institute of Medicine, Food and Nutrition Board. Washington DC, National Academy Press, 1998.
• 17. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Beta-Carotene, and other Carotenoids. Institute of Medicine, Food and Nutrition Board. Washington DC, National Academy Press, 2000.
• 18. Dietary Reference Intakes: Use in Dietary Assessment. Institute of Medicine, Food and Nutrition Board. Washington DC, National Academy Press, 2000.
• 19. Dietary Reference Intakes for Vitamin A, Boron, Chromium, Copper, Jodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium and Zinc. Institute of Medicine, Food and Nutrition Board. Washington DC, National Academy Press, 2001.
• 20. Donnelly J.G.: Folic acid. Crit. Rev. Clin. Lab. Sei., 2001, 3, 183-223.
• 21. Duan W., Ladenheim B., Cutler R.G., et al.: Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease. J. Neurochem., 2002, 1, 101-10.
• 22. FAO/WHO Expert Group. Requirements of vitamin A, iron, folate and vitamin B12, 1988.
• 23. German Nutr. Society, Austrian Nutr. Society, Swiss Society for Nutr. Research, Swiss Nutr. Association: Reference values for nutrient intake. Bonn, German Nutr. Society (DGE), Umschau- Verlag, 2002, 99-103.
• 24. Graham I.M., Daly L.E., Refsum H.M., et al.: Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. J. Am. Med. Assoc., 1997, 277, 1775-1781.
• 25. Graham I.M., O'Callaghan P: Vitamins, homocysteine and cardiovascular risk. Cardiovasc. Drugs. Ther., 2002, 16, 383-9.
• 26. Green N.S.: Folic acid supplementation and prevention of birth defects. J. Nutr., 2002, 132 (8 Suppl), 2356-2360.
• 27. Gregory J., Foster K., Tyler H.: The dietary and nutritional survey of British adults. London, HMSO, 1990, 109-112.
• 28. Gregory III J.F.: Bioavailability of folate. Europ. J. Clin. Nutr., 1997, 51, 54-59.
• 29. Hages M., Brönstrup A., Prinz-Langenohl R., et al.: Zur Aktualisierung der Deutschen Empfehlungen für die Folatzufuhr, Teil I. Ernährungs-Umschau 1999, 46, 248-251.
• 30. Johnson K.A., Bernard M.A., Funderburg K.: Vitamin nutrition in older adults. Clin. Geriatr. Med., 2002, 18, 773-99.
• 31. Kim Y.I.: Folate and carcinogenesis: evidence, mechanisms and implications. J. Nutr. Biochem., 1999, 10, 66-88.
• 32. Kruman II, Kumaravel T.S., Lohani A., et al.: Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J. Neurosci., 2002, 22(5), 1752-62.
• 33. Malinow M.R., Boston A. G., Kraus R.M.: Homocysteine, diet and cardiovascular disease. A statement for healthcare professionals for Nutrition Committee American Hearth Association. Circulation 1999, 178-182.
• 34. McPartlin J., Halligan A., Scott J.M., et al.: Accelerated folate breakdown in pregnancy. Lancet 1993, 341, 148-149.
• 35. Molloy A.M., Scott J.M.: Folates and prevention of disease. Public Health Nutr., 2001, 2B, 601-9.
• 36. Moore L.L., Bradlee M.L., Singer M.R., et al.: Folate intake and the risk of neural tube defects: an estimation of dose-response. Epidemiology 2003, 14, 200-5.
• 37. Neuhouser M.L., Beresford S.A.A.: Folic acid: are current fortification levels adequate? Nutrition 2001, 17, 10, 868-872.
• 38. Neal B., Mac Mahon S., Ohkubo T., et al.: Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease. Eur. Heart. J., 2002, 23, 1509-15.
• 39. O'Keefe C.A., Bailey L.B., Thomas E.A., et al.: Controlled dietary folate affects folate status in nonpregnant women. J. Nutr., 1995, 125, 2717- 2725.
• 40. Olney R.S., Mulinare J.: Trends in neural tube defect prevalence, folic acid fortification, and vitamin supplement use. Semin. Perinatol., 2002, 26, 277-85.
• 41. Prinz Langenohl R., Fohr I., Pietrzik K.: Beneficial role for folate in the prevention of colorectal and breast cancer. Eur. J. Nutr., 2001, 3, 98-105.
• 42. Quinlivan E.P., Gregory III J.F.: Effect of food fortification on folic acid intake in the United States. Am. J. Clin. Nutr., 2003, 77, 221-5.
• 43. Rogalska-Niedźwiedź M., Chabros E., Chwojnowska Z., et al.: Study of folate consumption in a group of women at childbearing age. Żyw. Człow. Metab., 2000, 27, 172.
• 44. Ray J.G., Laskin C.A.: Folic acid and homocysteine metabolic defects and the risk of placental abruption, preeclapsia and spontaneous pregnancy loss: a systematic review. Placente 1999, 20, 519.
• 45. Rosenberg K.D., Gelow J.M., Sandoval A.P: Pregnancy intendedness and the use of periconceptional folic acid. Pediatrics 2003, 111(5 Part 2),1142-5.
• 46. Satia-Abouta J., Kristal A.R., Patterson R.E., et al.: Dietary supplement use and medical conditions: the VITAL study. Am. J. Prev. Med., 2003, 24, 43-51.
• 47. Sauberlick H.E., Kretsch M.J., Skala J.H., et al.: Folate requirement and metabolism in nonpregnant women. Am. J. Clin. Nutr., 1987, 46, 1016-1028.
• 48. Sillender M.: The health benefits of folic acid. Leatherhead Food RA. Food Industry J., 2001, 4, 3, 263-273.
• 49. Snowdon D.A., Tully C.I., Smith D.C., et al.: Serum folate and severity of atrophy of neocortex in Alzheimer disease. Findings from the Nun. Study. Am. J. Clin. Nutr., 2000, 71, 993.
• 50. Stanowisko zespołu ekspertów Ministerstwa Zdrowia i Opieki Społecznej w sprawie zapobiegania wadom wrodzonym cewy nerwowej u potomstwa poprzez stosowanie kwasu foliowego. Żyw. Człow. Metab., 1997, 24, 1, 91-95.
• 51. Tice J.A., Ross E., Coxson PG., et al.: Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease. J. Am. Med. Assoc., 2001, 286, 8, 936-943.
• 52. Quinlivan E.P., Gregory III J.F.: Effect of food fortification on folic acid intake in the United States. Am. J. Clin. Nutr., 2003, 77, 221-5.
• 53. Vollser S.F., Refsum H., et al.: Plasma total homocysteine pregnancy complicationnnns and adverse pregnancy outcomes: the Horddaland Homocysteine Study. Am. J. Clin. Nutr., 2000, 71, 926.
• 54. Voutilainen S., Lakka T.A., Porkkala-Sarataho E., et al.: Low serum folate concentrations are associated with an excess incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. Eur. J. Clin. Nutr., 2000, 54, 424-428.
• 55. Wartanowicz M.: Żywieniowe aspekty biodostępności witamin rozpuszczalnych w wodzie. W: Witaminy i mikroelementy w żywieniu człowieka - biodostępność i stan odżywienia. Warszawa, Wyd. SGGW, 1998, 36-45.
• 56. Wartanowicz M., Charzewska J., Ziemlański Ś.: Stan odżywienia i sposób żywienia dzieci ze szkół podstawowych w Warszawie. Cz. IV. Witaminy w surowicy w latach 1971-1982. Żyw. Człow. Metab., 1985, 1, 17.
• 57. Wartanowicz M., Ziemlański Ś.: Vitamin status of institutionalized and own home living elderly. Żyw. Człow. Metab., 1992, 19, 156.
• 58. Wartanowicz M., Ziemlański Ś., Bułhak-Jachymczyk B.: Assessment of nutritional folate status and selected vitamin status of women of childbearing age. Eur. J. Clin. Nutr., 2001, 55, 9, 743.
• 59. Wartanowicz M., Ziemlański Ś., Rudnicki S.: Badania skriningowe nad zawartością witamin antyoksydacyjnych w surowicy krwi osób z niedokrwienną chorobą serca badanych w latach 1995-1996 w porównaniu z 1992 rokiem. Med. Met., 1998, 2, 5.
• 60. Wei M.M., Bailey L.B., Toth J.E, Gregory III J.F.: Bioavailability for humans of deuteriumlabeled monoglutamyl and polyglutamyl folates is affected by selected foods. J. Nutr., 1996, 126, 3100-3108.
• 61. Werler M.M., Shapiro S., Mitchell A.A.: Periconceptual folic acid exposure and risk of occurrent neural tube defect. J. Am. Med. Assoc., 1993, 269, 1257-1261.
• 62. Wolfram G.: Zufuhrempfehlungen und Nährstoffbedarf. Ernährungs-Umschau 1995, 42, 44-50.
• 63. Zając J., Wartanowicz M.: Obserwacje nad kształtowaniem się zawartości kwasu foliowego w I trymestrze ciąży. Krakowski Przegląd Gin. Pol., 1974, 2, 251.
• 64. Ziemlański Ś.: Normy żywienia człowieka. Wyd. 1. Warszawa, Wydanictwo Lekarskie PZWL, 2001, 244-260.
• 65. Ziemlański Ś., Bułhak-Jachymczyk B., Budzyńska-Topolowska J., i in.: Normy żywienia dla ludności w Polsce (energia, białko, tłuszcz, witaminy i składniki mineralne). Nowa Medycyna, 1998, 4, 17-19.
• 66. Ziemlański Ś., Wartanowicz M.: Kwas foliowy niezbędny mikroskładnik pożywienia. Mediapress, 1999, 5, 3-8.
• 67. Ziemlański S., Wartanowicz M.: Rola folianów w żywieniu kobiet i dzieci. Ped. Współ. Gastroenter., Hepat. Żyw. Dziecka, 2001, 3, 2, 119-125.
• 68. Ziemlański Ś., Wartanowicz M., Przepiórka M.: Rola kwasu foliowego w organizmie człowieka. W: Zapobieganie wrodzonym wadom cewy nerwowej. Pod red. Z.J. Brzeziński. Warszawa Wyd. Instytutu Matki i Dziecka, 1998.